Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pieter Muntendam

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Atherosclerosis Reports|July 30, 2011
The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic populationErling Falk, Henrik Sillesen, Pieter Muntendam, et al.
American Heart Journal|July 6, 2010
The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectivesPieter Muntendam, Carol McCall, Javier Sanz, et al.
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Identification of allergic disease among users of antihistaminesSheryl L Szeinbach, Brock Williams, Pieter Muntendam, et al.
Drug Discovery Today. Technologies|July 2, 2014
Lost in translation? Role of metabolomics in solving translational problems in drug discovery and developmentJan van der Greef, Aram Adourian, Pieter Muntendam, et al.
JACC. Cardiovascular Imaging|July 14, 2012
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage studyHenrik Sillesen, Pieter Muntendam, Aram Adourian, et al.
International Journal of Cardiology|June 7, 2011
Galectin-3 in heart failure: high levels are associated with all-cause mortalityThor Ueland, Pål Aukrust, Kaspar Broch, et al.
Journal of the American College of Cardiology|July 6, 2019
Negative Risk Markers for Cardiovascular Events in the ElderlyMartin Bødtker Mortensen, Valentin Fuster, Pieter Muntendam, et al.
European Journal of Heart Failure|January 8, 2013
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFTInder S Anand, Thomas S Rector, Michael Kuskowski, et al.
Clinical Chemistry|February 27, 2010
Risk factors for near-term myocardial infarction in apparently healthy men and womenBørge G Nordestgaard, Aram S Adourian, Jacob J Freiberg, et al.
Journal of the American College of Cardiology|August 27, 2016
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage StudyMartin Bødtker Mortensen, Valentin Fuster, Pieter Muntendam, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Atherosclerosis Reports|July 30, 2011
The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic populationErling Falk, Henrik Sillesen, Pieter Muntendam, et al.
American Heart Journal|July 6, 2010
The BioImage Study: novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease--study design and objectivesPieter Muntendam, Carol McCall, Javier Sanz, et al.
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Identification of allergic disease among users of antihistaminesSheryl L Szeinbach, Brock Williams, Pieter Muntendam, et al.
Drug Discovery Today. Technologies|July 2, 2014
Lost in translation? Role of metabolomics in solving translational problems in drug discovery and developmentJan van der Greef, Aram Adourian, Pieter Muntendam, et al.
JACC. Cardiovascular Imaging|July 14, 2012
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage studyHenrik Sillesen, Pieter Muntendam, Aram Adourian, et al.
International Journal of Cardiology|June 7, 2011
Galectin-3 in heart failure: high levels are associated with all-cause mortalityThor Ueland, Pål Aukrust, Kaspar Broch, et al.
Journal of the American College of Cardiology|July 6, 2019
Negative Risk Markers for Cardiovascular Events in the ElderlyMartin Bødtker Mortensen, Valentin Fuster, Pieter Muntendam, et al.
European Journal of Heart Failure|January 8, 2013
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFTInder S Anand, Thomas S Rector, Michael Kuskowski, et al.
Clinical Chemistry|February 27, 2010
Risk factors for near-term myocardial infarction in apparently healthy men and womenBørge G Nordestgaard, Aram S Adourian, Jacob J Freiberg, et al.
Journal of the American College of Cardiology|August 27, 2016
A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage StudyMartin Bødtker Mortensen, Valentin Fuster, Pieter Muntendam, et al.
Pageof 4